2021-2022 Stroke Fellowship Wrapup

Stroke Busters

Our stroke program, founded by Dr. James Grotta in 1979, specializes in stroke epidemiology, clinical trial design, and basic science. We train the next generation of revolutionary academics and leaders in cerebrovascular disease through our NINDS-funded fellowship programs. Each year we welcome a new class of fellows. This episode is a "wrap up" of their time with us this past year!

Hosts:

Amy Quinn, James Grotta, MD, Amanda Jagolino-Cole, MD

Guests (Fellows):

Drs. Stuart Fraser, Ivo Bach, Praveen Hariharan, Pamela Zelnik, Sishir Mannava

StrokeBusters, a Podcast

Presented by: The Institute for Stroke and Cerebrovascular Disease at the University of Texas Health Science Center at Houston (UTHealth) or “Stroke Institute"

About

StrokeBusters is a podcast series of recorded conversations on the topic of stroke and cerebrovascular disease. Based in the Texas Medical Center, the largest medical center in the world, we tap into our local network of astonishing leaders in healthcare and medicine to discuss the latest and most exciting news in stroke. Throughout this ten-episode series, we connect with UTHealth physicians and researchers, many who are experts in their field, to discuss their practice, cutting-edge research and medical care.

Who We Are

The Institute for Stroke and Cerebrovascular Disease, better known as the Stroke Institute, serves as a multi-disciplinary hub for research and best practices in stroke recovery, stroke prevention, services, population health, and vascular dementia. We are one of the most active research and clinical programs in the country, the first Comprehensive Stroke Center in the state, and launched the first Mobile Stroke Unit in the nation.

Contact

Web: http://www.utstrokeinstitute.com

Twitter: @UTHealthStroke

Instagram: @UTHealthStroke

Facebook: facebook.com/uthealthstroke

LinkedIn: @UTHealthStroke

Ideas and opinions are our own and this podcast is not a substitute for expert medical advice.

For more information or if you have any questions, please contact us at [e-mail]